Coagulation disorders are a common problem in neoplastic patients and many factors
contribute to increase the risk of thromboembolic events in these patients. An …

Thrombosis is a major cause of morbidity and mortality in cancer patients. The pathogenesis
of blood coagulation activation in oncological patients is complex and involves both clinical …

Cancer is a real model of acquired hypercoagulable state. A close interaction exists
between venous thromboembolic disease and cancer. Tumor progression is associated with …

The close relationship between cancer and thrombosis is known since more than a century.
Venous thromboembolism (VTE) may be the first manifestation of an occult malignancy in an …

A hypercoagulable or prothrombotic state of malignancy occurs due to the ability of tumor
cells to activate the coagulation system. It has been estimated that hypercoagulation …

Cancer-associated thrombosis (CAT) is a leading cause of mortality in cancer patients and
its incidence varies in different parts of the world. Venous thromboembolism (VTE) is a …

The association between cancer and thrombosis is known for years. Besides the well-
recognized connection between venous thromboembolism and malignancies, there are …

There is strong evidence linking venous thromboembolic events and malignancy.
Laboratory markers of coagulation activation such as thrombin–antithrombin complex or …

Purpose: We sought to determine whether venous thromboembolism in cancer patients is
associated with aberrant plasma levels of hemostatic and angiogenic factors. Patients and …

The relationship between increased clotting and malignancy is well recognized, though the
bidirectional development of this association is often overlooked. In the challenging cancer …